Intellectual Property India Publishes Patent Application for 'Anti-Fgfr2b Antibodies And Uses Thereof' Filed by 3H Pharmaceuticals Co. Ltd.

MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517041292 A) filed by 3H Pharmaceuticals Co. Ltd., Shanghai, on April 29, for 'anti-fgfr2b antibodies and uses thereof.'

Inventor(s) include Li, You; Wang, Ruiqin; Zhang, Jianwei; Zhou, Shanshan; Ping, Xianqiang; Lin, Jufang; Cai, Mingqing; and Hu, Shaojing.

The application for the patent was published on June 13, under issue no. 24/2025.

According to the abstract released by the Intellectual Property India: "The present invention generally relates to novel anti-FGFR2b antibodies and antigen-binding fragments thereof, which specifically bind fibroblast growth factor receptor 2b (FGFR2IIIb, or FGFR2b), and polynucleotides, vectors, cells, composit...